Medicare Enrolled

Dr. Gustavo Alva, M.D.

Psychiatry · Orange, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
302 W LA VETA AVE STE 202, Orange, CA 92866
7145455550
In practice since 2006 (19 years)
NPI: 1417030222 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alva? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alva

Dr. Gustavo Alva is a psychiatry specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Alva performed 3,941 Medicare services across 1,029 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alva received a total of $5,350,615 from 59 pharmaceutical and/or device companies across 6514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in CA $5,350,615 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,941
Medicare services
Top 2% in CA for psychiatry
1,029
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~207 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,931 $105 $221
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
867 $56 $146
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
640 $4 $10
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
230 $12 $29
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
87 $148 $296
Psychiatric services complicated by communication factor
Psychiatric evaluation or treatment provided when communication barriers complicate the interaction between the provider and the patient.
59 $12 $31
New patient office visit, complex (60-74 min) 54 $179 $422
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $66 $152
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
35 $74 $185
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,350,615
Total received (2018-2024)
Avg $764,374/year across 7 years
Top 0% in CA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
6,514
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,776,563 (89.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$327,752 (6.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$153,096 (2.9%)
Other
Charitable contributions, space rental, and other categories
$93,204 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,051,279
2023
$1,057,512
2022
$777,095
2021
$594,111
2020
$443,106
2019
$698,264
2018
$729,247

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$182,809
Vanda Pharmaceuticals Inc.
$122,227
Otsuka America Pharmaceutical, Inc.
$110,509
Axsome Therapeutics, Inc.
$100,795
Neuronetics, Inc.
$93,204
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$80,520
ABBVIE INC.
$74,435
E.R. Squibb & Sons, L.L.C.
$69,987
Alkermes, Inc.
$65,210
Janssen Pharmaceuticals, Inc
$55,702
Neurocrine Biosciences, Inc.
$41,201
ACADIA Pharmaceuticals Inc
$16,290
Otsuka Pharmaceutical Co., Ltd.
$13,571
Biogen, Inc.
$6,471
Noven Pharmaceuticals, Inc.
$5,756
LivaNova USA, Inc.
$5,272
Otsuka Pharmaceutical Development & Commercialization, Inc.
$4,179
H. Lundbeck A S
$1,500
Lundbeck LLC
$516
Supernus Pharmaceuticals, Inc.
$238
Noven Therapeutics, LLC
$181
Boehringer Ingelheim Pharmaceuticals, Inc.
$179
Bausch Health US, LLC
$145
HARMONY BIOSCIENCES LLC
$141
IDORSIA PHARMACEUTICALS US INC
$69
Indivior Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$33
Janssen Scientific Affairs, LLC
$28
Lilly USA, LLC
$20
IRONSHORE PHARMACEUTICALS INC.
$16
PFIZER INC.
$16
Top 3 companies account for 39.5% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$915,935
Otsuka America Pharmaceutical, Inc.
$493,584
Alkermes, Inc.
$444,641
Janssen Pharmaceuticals, Inc
$435,541
Allergan Inc.
$321,413
ACADIA Pharmaceuticals Inc
$304,510
Neurocrine Biosciences, Inc.
$279,684
ITI, Inc.
$220,692
Axsome Therapeutics, Inc.
$209,834
H. Lundbeck A S
$204,594
AbbVie Inc.
$200,920
ABBVIE INC.
$186,639
Avanir Pharmaceuticals, Inc.
$141,797
Vanda Pharmaceuticals Inc.
$136,618
Allergan, Inc.
$104,161
Neuronetics, Inc.
$93,913
Takeda Pharmaceuticals U.S.A., Inc.
$87,304
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$80,520
Neurocrine BioSciences, Inc.
$77,000
Sunovion Pharmaceuticals Inc.
$76,972
E.R. Squibb & Sons, L.L.C.
$69,987
Noven Pharmaceuticals, Inc.
$54,586
LivaNova USA, Inc.
$49,761
Eisai Inc.
$39,787
Indivior Inc.
$32,277
Biogen, Inc.
$21,453
Otsuka Pharmaceutical Co., Ltd.
$16,571
Sage Therapeutics, Inc.
$14,977
IDORSIA PHARMACEUTICALS US INC
$11,146
Otsuka Pharmaceutical Development & Commercialization, Inc.
$7,357
Alfasigma USA, Inc.
$4,684
Merck Sharp & Dohme Corporation
$3,818
Corium, LLC
$1,550
Lundbeck LLC
$1,302
Novartis Pharmaceuticals Corporation
$1,253
Bausch Health US, LLC
$524
Noven Therapeutics, LLC
$520
Boehringer Ingelheim Pharmaceuticals, Inc.
$438
Harmony Biosciences LLC
$427
Supernus Pharmaceuticals, Inc.
$327
Adlon Therapeutics L.P.
$205
Brainsway USA INC
$197
Shire North American Group Inc
$186
HARMONY BIOSCIENCES LLC
$159
Ironshore Pharmaceuticals Inc.
$135
Biohaven Pharmaceutical Holding Company Ltd.
$120
ARBOR PHARMACEUTICALS, INC.
$112
Merck Sharp & Dohme LLC
$79
Janssen Scientific Affairs, LLC
$75
Lilly USA, LLC
$69
Almatica Pharma LLC
$58
EISAI INC.
$36
PFIZER INC.
$34
Azurity Pharmaceuticals, Inc.
$33
Tris Pharma Inc
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$23
US WorldMeds, LLC
$17
IRONSHORE PHARMACEUTICALS INC.
$16
Brainsway USA Inc
$11
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · ADUHELM · AMYVID · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adlarity · Aduhelm · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · BrainsWay Deep TMS · Brainsway Deep TMS · CAPLYTA · COBENFY · COMIRNATY · DASOTRALINE · DISEASE EDUCATION · Dayvigo · Dyanavel XR · Evekeo · FANAPT · Fanapt · GRALISE · HETLIOZ · Hetlioz · Horizant · INGREZZA · INVEGA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KAPSPARGO · KESIMPTA · KISUNLA · LATUDA · LONHALA MAGNAIR · LOREEV XR · LYBALVI · Lucemyra/Lofexidine · MYDAYIS · NAMZARIC · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NUPLAZID · NURTEC ODT · None · Nuedexta · ONGENTYS · PERSERIS · QELBREE · QULIPTA · QUVIVIQ · Qelbree · REJOYN · REXULTI · SECUADO · SPRAVATO · Secuado · Sunosi · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIIBRYD · VIVITROL · VNS - Symmetry · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VNS Therapy · VNS Therapy Symmetry Model 8103 Generator · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · Vyvanse · WAKIX · WELLBUTRIN · WELLBUTRIN XL · Wakix · Xelstrym · ZULRESSO · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for psychiatry in CA.

Looking for a psychiatry specialist in Orange?
Compare psychiatrists in the Orange area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
912
Per 100K population
28.8
County median income
$113,702
Nearest hospital
HEALTHBRIDGE CHILDREN'S HOSPITAL - ORANGE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Alva is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Alva experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Alva performed 1,931 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alva receive payments from pharmaceutical companies?
Yes. Dr. Alva received a total of $5,350,615 from 59 companies across 6,514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alva's costs compare to other psychiatrists in Orange?
Dr. Alva's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →